Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-18 Sale | 2024-11-20 6:05 pm | Atara Biotherapeutics Inc. | ATRA | Henrich Jill EVP, Chief Regulatory Officer | 1,000 | $11.2 | $11,198 | 19,378 (Direct) | View |
| 2024-08-16 Sale | 2024-08-20 6:26 pm | Atara Biotherapeutics Inc. | ATRA | Henrich Jill EVP, Global Head RA & Quality | 963 | $6.6293 | $6,384 | 20,378 (Direct) | View |
| 2024-05-16 Sale | 2024-05-20 8:32 pm | Atara Biotherapeutics Inc. | ATRA | Henrich Jill EVP, Global Head RA & Quality | 25,750 | $0.617 | $15,888 | 529,251 (Direct) | View |
| 2024-03-04 Sale | 2024-03-06 6:16 pm | Atara Biotherapeutics Inc. | ATRA | Henrich Jill EVP, Global Head RA & Quality | 3,879 | $0.72 | $2,793 | 555,001 (Direct) | View |
| 2023-11-16 Sale | 2023-11-20 5:29 pm | Atara Biotherapeutics Inc. | ATRA | Henrich Jill EVP, Global Head RA & Quality | 3,267 | $0.389 | $1,271 | 104,424 (Direct) | View |
| 2023-08-16 Sale | 2023-08-18 6:25 pm | Atara Biotherapeutics Inc. | ATRA | Henrich Jill EVP, Global Head RA & Quality | 3,346 | $1.6532 | $5,531 | 107,691 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-08 Option Award | 2024-01-09 4:40 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Henrich Jill EVP, Global Head RA & Quality | 450,000 | $0 | 558,880 (Direct) | View |
Ownership | 2023-06-09 4:30 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Henrich Jill EVP, Global Head RA & Quality | 0 | $0 | 353,115 (Direct) | View |